BNCM: DELEX ANNOUNCE EXPANSION PLANS FOR ITS PHARMACY

The Philippines, with its population exceeding 114 million across 7,641 islands, presents a strong opportunity for growth in the pharmacy retail industry. The countrys expanding population, rising economy, and increasing incomes are driving higher demand globally for healthcare products and services.

ABOUT DELEX PHARMACY

DELEX Pharmacy, now in its third year of operation, is a licensed retail drugstore offering a comprehensive range of affordable and high-quality pharmaceutical products, health supplements, medical supplies, personal care items, and other essential healthcare needs. The product portfolio includes both branded and unbranded non-originator medications, over-the-counter (OTC) drugs, prescription medications, and various health and wellness products, alongside the companys own line of originator brands.

To strengthen and sustain its market presence, DELEX Pharmacy has strategically established physical stores, providing customers with easier access to its products. The company opened its first drugstore in Barangay Sauyo, Quezon City, Philippines, on October 18, 2021, followed by a second location in Santolan, Pasig City, in December 2022, and a third branch in Kalibo, Aklan, in July 2023. In addition to its brick-and-mortar establishments, DELEX Pharmacies offer 24-hour online ordering through its official Facebook accounts and are also active on major e-commerce platforms such as Lazada, Shopee, and TikTok Shop. These digital channels contribute significantly to DELEX’s sales volume, complementing its physical store operations.

DELEXs commitment to service excellence is evident in its robust customer care offerings, including free face-to-face medical consultations for the community, pharmacist assistance, and patient counseling, all communicated through its official online channels. To further support patient convenience, DELEX provides free express delivery services within a 10-kilometer radius for orders meeting a minimum purchase threshold. Caring deeply for its customers’ health, the organization offers online ordering, reducing exposure to communicable diseasesa feature especially vital for vulnerable patients.

In addition to serving patients, DELEX Pharmacy supports prescribing doctors within its partner hospitals, enabling them to conveniently direct patients to the pharmacy for their prescriptions, thereby boosting corporate sales. Through its focus on customer care, accessibility, and affordability, DELEX Pharmacy effectively addresses key gaps in the healthcare market, establishing itself as a trusted and customer-centric provider in the pharmaceutical industry.

EXPANSION GOALS

Driven by favorable market conditions and rising demand, DELEX Pharmacy aims to expand to 60 pharmacy stores, supported by additional shares and funding. The Philippine Pharmaceutical Industry Roadmap projects domestic drug production and government procurement shares to grow to 60% and 50% over the next six to ten years, further supporting industry growth. Hence, the organization is optimistic about the future, particularly with the support of government initiatives under the Universal Healthcare program.

About Bounce Mobile Systems, Inc. (OTC: BNCM)

BNCM is an Asset Management Company that secures its assets by investing in companies with strong growth potentials, robust revenues, significant profits, proven track records, and promising business models with highly experienced management teams that will exceptionally qualify for quotation and listing on the OTC or NASDAQ markets within the next 2 to 3 years. The growth of these companies will directly provide more employment opportunities to the communities, improve the country’s economy, and bring greater social change.

For more information, visit: https://www.bncm.net/

About Delex Healthcare Group, Inc. (DELEX)

DELEX is a Delaware-registered company, and the holding company of DLX Holdings, Inc. (DLX). DLX is a Philippine-based parent company that holds a 60% controlling interest in Delex Pharma International, Inc. an ISO 9001-2015 Certified company, which also holds a controlling interest in JMN Brother’s Pharma Limited, Inc. DLX and its subsidiaries are involved in the development and distribution of pharmaceutical and healthcare products in the Philippines.

For more information, visit: https://delexhealth.com